Remarkably, HSP90 is pivotal for Tyk2 stability and function (Akahane et al., 2016; Reynolds and Blagg, 2024), where HSP90 suppression following PU-H71 treatment has been reported to cause Tyk2 and inactivation of Tyk2, in various cancer models. This evidence concerns the gene TYK2 and cancer.